<DOC>
	<DOC>NCT01418989</DOC>
	<brief_summary>This open-label, multi-center study will compare the bioavailability of RoActemra/Actemra (tocilizumab) administration by auto-injector versus pre-filled syringe in healthy volunteers. Healthy volunteers will receive a single dose of RoActemra/Actemra (tocilizumab). The anticipated time of study duration is 28 days.</brief_summary>
	<brief_title>A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy volunteers, age 18 to 65 years inclusive Intact normal skin without potentially obscuring tattoos, pigmentation, lesion in the area for intended injection A body mass index (BMI) between 18 to 32 kg/m2 inclusive Volunteers with any known active current or history of recurrent bacterial, viral, fungal, mycobacterial or other infections A history of clinically significant gastrointestinal, renal, hepatic, cardiovascular, or allergic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>